Our blog provides updates on Absolute Antibody’s technologies, products and services. Browse the latest posts to learn about company developments and events.

Partnering with University of Zurich on SARS-CoV-2 Synthetic Nanobodies

Nucleoprotein Antibodies for SARS-CoV-2

ACE2 Fc Fusion Proteins Now Available for Coronavirus Research

VivopureX™ Antibody Collection Expands

Absolute Antibody Wins Queen’s Award for Enterprise

Anti-SARS-CoV-2 / COVID-19 Antibody: In Stock and New Formats

Supporting Coronavirus Research

Anti-SARS Antibody Turned Anti-COVID-19

FleXpress™ High-Throughput Recombinant Antibody Production Service

Partnering with the Technical University of Denmark on Antibodies against Animal Venom Toxins

You’re Invited! Brews & Biopharma Networking Night

New Podcast Featuring Our CSO

VivopureX™ Antibodies for In Vivo Research Launched at Bulk-Discounted Prices

Absolute Antibody Partners with the Recombinant Antibody Network

Optimizing an Antibody for Glioblastoma Treatment: An Antibody Humanization Case Study

Recombinant Antibodies for Integrin Tumor Research and Diagnostics

The Periodic Table of Antibodies

New: Veterinary IgE Fc Proteins

Online Antibody Engineering Lecture from our CSO

New: Fully Murine Knob-Into-Hole Bispecifics

Engineered, Species-Matched Antibody Allowed for Long-Term CD8+ T-Cell Depletion in Mice

Absolute Antibody Receives CIR Accreditation

Custom Purification Systems for High-Throughput Recombinant Antibody Production

Saving a Malaria Antibody with Therapeutic Potential – Hybridoma Sequencing Case Study

Anti-DNA/RNA Hybrid Antibody S9.6 Available In New Engineered Formats

Absolute Antibody Receives ISO 9001:2015 Certification

2018: A Year of Expansion

Absolute Antibody Opens New Facility

CHI’s Bispecific Antibody Pipeline Congress 2018

Antibody Engineering News – Absolute Antibody’s Newsletter